首页> 外国专利> METHODS FOR PREDICTING THREE-DIMENSIONAL STRUCTURES FOR ALPHA HELICAL MEMBRANE PROTEINS AND THEIR USE IN DESIGN OF SELECTIVE LIGANDS

METHODS FOR PREDICTING THREE-DIMENSIONAL STRUCTURES FOR ALPHA HELICAL MEMBRANE PROTEINS AND THEIR USE IN DESIGN OF SELECTIVE LIGANDS

机译:Alpha螺旋膜蛋白的三维结构预测方法及其在选择性配体设计中的应用

摘要

A method for practical prediction of the three-dimensional structure of α-helical membrane proteins (HMPs) is described. The method allows one to predict the binding site and structure for strongly bound ligands. The method combines a protocol of computational methods enabling a complete ensemble of packings to be sampled and systematically reducing this ensemble to progressively more accurate structures until at the end there remain a few that might be functionally relevant and likely to play a role in all binding and activation processes. This method is well suited to automatic operation making it practical to obtain, for example, the ensemble of important structures for all human GPCRs. With this ensemble of all active GPCR structures in the human body, an infimum method is presented to maximize efficacy toward the selected target while minimizing binding to all other GPCRs to eliminate toxicity arising from cross-reacting with other GPCRs (a most common source of drug failure). This infimum method is broadly applicable to any set of proteins where a ligand is desired to be able to modulate the function of one protein while not affecting the function of other proteins.
机译:描述了一种实用的α-螺旋膜蛋白(HMPs)三维结构预测方法。该方法可以预测强结合的配体的结合位点和结构。该方法结合了计算方法的协议,可以对包装的完整集合进行采样,并系统地将该集合减少为逐渐更精确的结构,直到最后剩下一些在功能上可能相关并且可能在所有绑定和匹配中起作用的元素。激活过程。该方法非常适合于自动操作,使它变得实用,例如,获得了所有人类GPCR的重要结构的集合。结合人体中所有活性GPCR结构的全貌,提出了一种最有效的方法,可以最大限度地提高针对所选靶标的功效,同时最大程度地减少与所有其他GPCR的结合,从而消除与其他GPCR交叉反应(最常见的药物来源)所产生的毒性失败)。这种最低限度的方法广泛适用于希望配体能够调节一个蛋白质的功能而不影响其他蛋白质功能的任何蛋白质组。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号